Nicolás Lundahl Ciano-Petersen

TL;DR: Despite the short evolution time of the cases surviving the current pandemic, the description of cases of post‐infectious neurological syndromes suggests that this is probably not an infrequent complication in the subacute stage of Covid‐19 disease.

TL;DR: COVID-19 cumulative incidence was higher in patients with active epilepsy and Epilepsy was associated with fatality during hospitalization, and Hypertension was associatedwith fatality in patientsWith active epilepsy.

TL;DR: In this article , a cross-sectional multicentric study of patients who survived severe infection with SARS-CoV-2 consecutively recruited between 90 and 120 days after hospital discharge was conducted.

TL;DR: Progress has additionally been made in the clinical characterization of patients with the main neural antibodies, which, although typically present with a subacute pancerebellar syndrome, may also show either hyperacute or chronic onsets that complicate the differential diagnoses.

TL;DR: A narrative review on the recent advances on the basic epileptogenic mechanisms related to the activation of immunity or neuroinflammation with special attention to current and future opportunities for novel treatments in epilepsy.